Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

NCT01963208 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

405

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Resistant Partial Onset Seizure

Interventions

DRUG: ganaxolone
DRUG: Placebo

Sponsor

Marinus Pharmaceuticals